The selective serotonin reuptake inhibitors (SSRIs) have the best established tolerance and safety profile of the available antidepressants. Evidence for this conclusion comes from controlled clinical trials, post-marketing surveillance, prescription audits and case reports. Comparative studies are
Tolerability and safety aspects of mirtazapine
β Scribed by David J. Nutt
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 90 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.388
No coin nor oath required. For personal study only.
β¦ Synopsis
The tolerability and safety profile of the noradrenergic and specific serotonergic antidepressant (NaSSA) mirtazapine reflects its unique pharmacological profile. The 5-HT(2) blocking effect contributes towards its anxiolytic effects and benefits on sleep, as well as preventing the sexual dysfunction that may occur with non-specific stimulation of the serotonin system by drugs such as the selective serotonin reuptake inhibitors (SSRIs). In addition, 5-HT(3) blockade by mirtazapine helps to prevent nausea and vomiting. Weight gain is the most commonly reported side-effect of mirtazapine, although there is evidence to suggest that this is not a significant problem during long-term treatment. In conclusion, mirtazapine has a good tolerability and safety profile that demonstrates several benefits over other antidepressants.
π SIMILAR VOLUMES
Improving drug safety and tolerability in psychiatric clinical practice y Psychiatric drugs, like all drugs, are associated with a range of adverse effects. Sometimes these are trivial but when severe they can impair quality of life, lead to poor adherence with medication, cause physical morbidity a
## Abstract Uncertainty and inequality are the most important phenomena that lead to the situation in which the modern technical age, in contrast to the premodern technical phase, gives rise to specifically moral problems which in the premodern era played only a marginal role or no role at all. So
## Abstract ## Objective To study how implementation of a naturalistic trial design for mirtazapine treatment in major depressive disorder for six (up to 12) months could be used and evaluated by means of clinical efficacy and safety. ## Method An openβlabelled, prospective, multicenter, nonβcom